Ilary Ruscito1,2, Maria Luisa Gasparri3,4, Elena Ioana Braicu2, Filippo Bellati5, Luigi Raio6, Jalid Sehouli2, Michael D Mueller6, Pierluigi Benedetti Panici1, Andrea Papadia6. 1. Department of Gynecology, Obstetrics and Urology, Sapienza University of Rome, Rome, Italy. 2. Department of Gynecology, Campus Virchow Clinic, Charité Medical University, Berlin, Germany. 3. Department of Gynecology, Obstetrics and Urology, Sapienza University of Rome, Rome, Italy. marialuisa.gasparri@uniroma1.it. 4. Department of Obstetrics and Gynecology, University Hospital of Berne and University of Berne, Berne, Switzerland. marialuisa.gasparri@uniroma1.it. 5. Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, S. Andrea Hospital, Rome, Italy. 6. Department of Obstetrics and Gynecology, University Hospital of Berne and University of Berne, Berne, Switzerland.
Abstract
BACKGROUND: Historically, blue dyes, (99)Tc or a combination of the two tracers have been used for sentinel lymph node (SLN) mapping in cervical and endometrial cancer patients. Indocyanine green (ICG), as a tracer, has been recently introduced in this setting. Our goal was to assess the differences in overall and bilateral detection rates as well as in false-negative rates among the different tracers. METHODS: The electronic databases PubMed, MEDLINE, and Scopus were searched in January 2016 by searching the terms "sentinel lymph node" and "dye" and "indocyanine green," and "cervical cancer" or "endometrial cancer." Series comparing different tracers injected intracervically and reporting the detection rate and/or SLN false-negative rate were selected. RESULTS: Forty-five studies were retrieved. Six studies including 538 patients met selection criteria. Compared with blue dyes, ICG SLN mapping had higher overall (odds ratio [OR] 0.27; 95 % confidence interval [CI] 0.15-0.50; p < 0.0001) and bilateral detection rates (OR 0.27; 95 % CI 0.19-0.40; p < 0.00001). No differences were found between ICG and (99)TC, although these results are based on data of a single series. No differences in overall and bilateral detection rates were found between ICG and the combination of blue dyes and (99)TC. The pooled analysis of false-negative rates data showed no difference in false-negative rates between tracers. CONCLUSIONS: In cervical and endometrial cancer, ICG SLN mapping seems to be equivalent to the combination of blue dyes and (99)TC in terms of overall and bilateral detection rates. Its safety profile and ease of use may favor its employment respect to conventional tracers.
BACKGROUND: Historically, blue dyes, (99)Tc or a combination of the two tracers have been used for sentinel lymph node (SLN) mapping in cervical and endometrial cancerpatients. Indocyanine green (ICG), as a tracer, has been recently introduced in this setting. Our goal was to assess the differences in overall and bilateral detection rates as well as in false-negative rates among the different tracers. METHODS: The electronic databases PubMed, MEDLINE, and Scopus were searched in January 2016 by searching the terms "sentinel lymph node" and "dye" and "indocyanine green," and "cervical cancer" or "endometrial cancer." Series comparing different tracers injected intracervically and reporting the detection rate and/or SLN false-negative rate were selected. RESULTS: Forty-five studies were retrieved. Six studies including 538 patients met selection criteria. Compared with blue dyes, ICG SLN mapping had higher overall (odds ratio [OR] 0.27; 95 % confidence interval [CI] 0.15-0.50; p < 0.0001) and bilateral detection rates (OR 0.27; 95 % CI 0.19-0.40; p < 0.00001). No differences were found between ICG and (99)TC, although these results are based on data of a single series. No differences in overall and bilateral detection rates were found between ICG and the combination of blue dyes and (99)TC. The pooled analysis of false-negative rates data showed no difference in false-negative rates between tracers. CONCLUSIONS: In cervical and endometrial cancer, ICG SLN mapping seems to be equivalent to the combination of blue dyes and (99)TC in terms of overall and bilateral detection rates. Its safety profile and ease of use may favor its employment respect to conventional tracers.
Authors: Maria Luisa Gasparri; Donatella Caserta; Pierluigi Benedetti Panici; Andrea Papadia; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2018-11-20 Impact factor: 4.553
Authors: Andrea Papadia; Maria Luisa Gasparri; Sophie Genoud; Klaeser Bernd; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2017-07-01 Impact factor: 4.553
Authors: Antonio Raffone; Antonio Travaglino; Angela Santoro; Italia Esposito; Giuseppe Angelico; Saveria Spadola; Gian Franco Zannoni Journal: Pathol Oncol Res Date: 2019-08-23 Impact factor: 3.201
Authors: Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2017-08-21 Impact factor: 4.553
Authors: Andrea Papadia; Ignacio Zapardiel; Beatrice Bussi; Fabio Ghezzi; Marcello Ceccaroni; Elena De Ponti; Federica Elisei; Sara Imboden; Begoña Diaz de la Noval; Maria Luisa Gasparri; Giampaolo Di Martino; Javier De Santiago; Michael Mueller; Francesca Vecchione; Federica Dell'Orto; Alessandro Buda Journal: J Cancer Res Clin Oncol Date: 2016-11-03 Impact factor: 4.553